Sugammadex and Decreased Time to Extubation

NCT03196167 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Bypass Graft and/or Aortic Valve Replacement Surgery

Interventions

DRUG: Sugammadex
OTHER: Placebo

Sponsor

Yale University

Collaborators

[object Object]